Andrea Martoni

4.1k total citations
122 papers, 2.5k citations indexed

About

Andrea Martoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Andrea Martoni has authored 122 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in Andrea Martoni's work include Cancer Treatment and Pharmacology (40 papers), Colorectal Cancer Treatments and Studies (23 papers) and Gastric Cancer Management and Outcomes (15 papers). Andrea Martoni is often cited by papers focused on Cancer Treatment and Pharmacology (40 papers), Colorectal Cancer Treatments and Studies (23 papers) and Gastric Cancer Management and Outcomes (15 papers). Andrea Martoni collaborates with scholars based in Italy, United States and Germany. Andrea Martoni's co-authors include F Pannuti, V. Mutri, E Piana, Carmine Pinto, Francesca Di Fabio, Salvatore Siena, S. Giaquinta, M. Guaraldi, Claudio Ceccarelli and Fabiola Lorena Rojas Llimpe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Andrea Martoni

120 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Martoni Italy 28 1.5k 916 712 314 242 122 2.5k
Guy C. Toner Australia 32 1.4k 0.9× 1.2k 1.3× 1.4k 1.9× 609 1.9× 118 0.5× 124 3.6k
Ralph Levitt United States 27 2.1k 1.4× 892 1.0× 682 1.0× 670 2.1× 185 0.8× 67 3.6k
Jason A. Zell United States 34 2.0k 1.3× 1.7k 1.8× 618 0.9× 527 1.7× 295 1.2× 130 3.7k
Gerardo Colón‐Otero United States 30 2.0k 1.3× 608 0.7× 618 0.9× 595 1.9× 411 1.7× 99 3.5k
Giles F. Whalen United States 27 1.4k 0.9× 573 0.6× 1.1k 1.6× 504 1.6× 113 0.5× 73 2.6k
Gianmauro Numico Italy 28 1.1k 0.8× 776 0.8× 531 0.7× 569 1.8× 238 1.0× 115 2.6k
Tetsu Shinkai Japan 29 2.0k 1.3× 1.8k 1.9× 401 0.6× 782 2.5× 196 0.8× 146 3.2k
Michael A. Savin United States 26 1.8k 1.2× 716 0.8× 430 0.6× 239 0.8× 285 1.2× 61 3.0k
Mahmut Gümüş Türkiye 27 2.2k 1.5× 1.2k 1.3× 757 1.1× 466 1.5× 144 0.6× 174 3.7k
Cinzia Orlandini Italy 29 2.2k 1.4× 877 1.0× 748 1.1× 622 2.0× 132 0.5× 74 3.7k

Countries citing papers authored by Andrea Martoni

Since Specialization
Citations

This map shows the geographic impact of Andrea Martoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Martoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Martoni more than expected).

Fields of papers citing papers by Andrea Martoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Martoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Martoni. The network helps show where Andrea Martoni may publish in the future.

Co-authorship network of co-authors of Andrea Martoni

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Martoni. A scholar is included among the top collaborators of Andrea Martoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Martoni. Andrea Martoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martoni, Andrea & Elena Strocchi. (2018). Accessibilità di cure palliative domiciliari e luogo del decesso dei malati oncologici: analisi dei dati della Regione Emilia-Romagna. Recenti Progressi in Medicina. 109(3). 185–192. 2 indexed citations
2.
Pinto, Carmine, Francesca Di Fabio, Evaristo Maiello, et al.. (2011). Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study). Annals of Oncology. 22(11). 2424–2430. 46 indexed citations
3.
Martoni, Andrea, Francesca Di Fabio, Carmine Pinto, et al.. (2010). Prospective study on the FDG–PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Annals of Oncology. 22(3). 650–656. 68 indexed citations
4.
Zamagni, Claudio, Ralph M. Wirtz, Pierandrea De Iaco, et al.. (2009). Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies. Endocrine Related Cancer. 16(4). 1241–1249. 15 indexed citations
5.
Lombardi, Raffaele, Dajana Cuicchi, Carmine Pinto, et al.. (2009). Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment?. Annals of Surgical Oncology. 17(3). 838–845. 30 indexed citations
6.
Martoni, Andrea, Barbara Melotti, Francesca Sperandi, et al.. (2008). Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: A phase II study. Lung Cancer. 60(3). 387–392. 7 indexed citations
7.
8.
9.
Nanni, Cristina, Paolo Castellucci, Mohsen Farsad, et al.. (2004). Role of 18 F-FDG PET for Evaluating Malignant Pleural Mesothelioma. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 149–154. 23 indexed citations
10.
Costa, Silvano, Patrizia Terzano, Donatella Santini, et al.. (2001). Neoadjuvant Chemotherapy in Cervical Carcinoma. American Journal of Clinical Pathology. 116(5). 729–737. 28 indexed citations
11.
Martoni, Andrea, Enrico Mini, Carmine Pinto, et al.. (2001). Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma. Annals of Oncology. 12(4). 519–524. 18 indexed citations
12.
Martoni, Andrea, Bruna Angelelli, M. Guaraldi, Elena Strocchi, & F Pannuti. (1996). An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens. European Journal of Cancer. 32(1). 82–85. 17 indexed citations
13.
Martoni, Andrea, et al.. (1993). A Phase II Study of Carboplatin and Cyclophosphamide in Advanced Ovarian Carcinoma. Journal of Chemotherapy. 5(1). 47–51. 10 indexed citations
14.
Martoni, Andrea, Barbara Melotti, M. Guaraldi, & F Pannuti. (1991). Activity of high-dose epirubicin in advanced non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. 27(10). 1231–1234. 26 indexed citations
15.
16.
Strocchi, Elena, C. M. Camaggi, Andrea Martoni, et al.. (1991). Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses. Cancer Chemotherapy and Pharmacology. 27(6). 451–455. 5 indexed citations
17.
Martoni, Andrea, et al.. (1990). Cisplatinum plus Epirubicin Alternated with Cyclophosphamide plus 5-Fluorouracil in Ovarian Cancer. Journal of Chemotherapy. 2(1). 62–66. 4 indexed citations
18.
Martoni, Andrea, et al.. (1990). Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast Cancer. Oncology. 47(5). 427–432. 24 indexed citations
19.
20.
Martoni, Andrea, et al.. (1989). Four-Year Analysis of Platinum and Anthracycline Combination for Ovarian Cancer. Oncology. 46(2). 109–116. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guy C. Toner Breakdown of academic impact, for papers by Ralph Levitt Breakdown of academic impact, for papers by Jason A. Zell Breakdown of academic impact, for papers by Gerardo Colón‐Otero Breakdown of academic impact, for papers by Giles F. Whalen Breakdown of academic impact, for papers by Gianmauro Numico Breakdown of academic impact, for papers by Tetsu Shinkai Breakdown of academic impact, for papers by Michael A. Savin Breakdown of academic impact, for papers by Mahmut Gümüş Breakdown of academic impact, for papers by Cinzia Orlandini
Rankless by CCL
2026